Introduction {#s1}
============

With the development of surgical techniques and biomaterial science, cataract surgery with intraocular lens (IOL) implantation has brought great benefits for patients. However, posterior capsule opacification (PCO), remains the most frequent long-term complication [@pone.0077864-Cheng1], decreasing the visual performance in 1 or 2 years after cataract surgery. Although treatment with Nd:YAG laser capsulotomy is effective, the complications, such as retina detachment, macular edema, intraocular pressure elevation [@pone.0077864-Kugelberg1], cannot be ignored.

Intraocular lens, with various designs and materials, have been observed in playing a vital role in the developmentof PCO. Two areas of concern are the biomaterials and the edge design of IOLs. Studies have shown that the rate of PCO with sharp edge designed IOLs was lower due to the inhibition of lens epithelial cells (LECs) migration [@pone.0077864-Buehl1], [@pone.0077864-Buehl2]. Acrylic IOLs with hydrophilic or hydrophobic surfaces, as two types of biocompatibility materials, safe for intraocular implantation, have a long history of clinical practice and have shown significantly lower rates of PCO and less Nd:YAG laser capsulotomy [@pone.0077864-Findl1]--[@pone.0077864-Heatley1]. Studies found that acrylic material has a relatively low propensity to induce cell proliferation in the capsular bag [@pone.0077864-Apple1]. Yet whether the hydrophilic or hydrophobic IOLs are better for PCO prevention remains controversial.

Numerous studies have compared on PCO to different designs and materials combinations of IOLs. Few comparative studies, however have evaluated the differences between hydrophobic acrylic IOLs and hydrophilic acrylic IOLs with the same edge design specifically. The aim of this meta-analysis is to investigate the differences between hydrophobic and hydrophilic IOLs with the same edge design in the development of PCO and the rate of Nd:YAG laser capsulotomy in a 2 year period.

Materials and Methods {#s2}
=====================

Literature Search {#s2a}
-----------------

This review was conducted following the QUOROM guideline standards [@pone.0077864-RamosMacias1]. Reports of randomized controlled trials (RCTs) comparing hydrophobic acrylic and hydrophilic acrylic IOLs in patients after phacoemulsification with IOL implantation were identified through a computerized literature search. The systematic search was conducted in the PubMed, EMBASE, and Cochrane Controlled Trials Register database up to the end of May 2013 by using the search terms "*posterior capsular opacification*" "*intraocular lens*" "*hydrophilic*" "*hydrophobic*" and limiting the search to reports of randomized controlled trials. The abstract of all potentially relevant articles were screened to determine their relevance followed by evaluation of candidate full articles. In addition, literature reference proceedings were scanned manually to obtain extra eligible trials until no more relevant trials were found in databases. For data collected from duplicate patient groups, only the most recent studies were included in each part of meta-analysis. The process of trials selection is shown in [Figure 1](#pone-0077864-g001){ref-type="fig"}. Two independent investigators performed the literature search (YL, JXW).

![Flow chart of literature search and study selection.](pone.0077864.g001){#pone-0077864-g001}

Selection Criteria {#s2b}
------------------

Selected trials fulfilling the following inclusion criteria were used in this analysis: (1) prospective design, randomized controlled trial; (2) population, patients with senile cataract undergoing cataract surgery; (3) intervention, phacoemulsification and IOL implantation; (4) comparison, hydrophobic acrylic and hydrophilic acrylic IOLs; all involved IOLs are designed with sharp edge;(5) outcome variables, at least one of the following primary outcome variables: PCO score, Nd:YAG capsulotomy rate.

Exclusion criteria were as follows: (1) patients with a history of ocular diseases other than senile cataract; (2) patients with a history of intraocular surgery other than IOL; (3) Cases with intraoperative complications, such as incomplete continuous curvilinear capsulorhexis (CCC), posterior capsule rupture or whose with postoperative complications (eg, iris synechia); (4) follow-up time of less than one year.

Data Extraction and Quality Assessment {#s2c}
--------------------------------------

Two reviewers (YL, JXW) completed searches independently according to the above the criteria, assessed the methodological quality of trials and extracted data from each eligible randomized clinical trial results. Differences were resolved by discussion to reach consensus between the investigators and results were checked by the third author (ZC) when required. The following items were collected from each trial: author\'s name, year of publication, design of study, patients\' mean age, gender, group size, IOL biomaterials and special designs, evaluation of PCO, and Nd:YAG capsulotomy (number or rate), follow-up period, respectively.

Outcome Measures {#s2d}
----------------

The primary outcome measure was the difference in PCO intensity or PCO score from software between the 2 types of IOLs at 1-year and 2-year follow-up post-operation. The secondary outcome measures were Nd:YAG capsulotomy rate at 2-year follow-up post-operation. For those patients who underwent Nd:YAG capsulotomy, the PCO value just before Nd:YAG capsulotomy was used for further statistical analysis. If there was more than 1 published report on the same population or group of patients, the most recent results with complementary data from previous articles were used for statistical analysis.

Statistical Analysis and Assessment of Heterogeneity {#s2e}
----------------------------------------------------

According to various measurement scales, PCO severity outcomes, as continuous data, were pooled using standardized mean differences (SMD) with 95% confidence intervals (CIs)[@pone.0077864-Zhu1]. The data of Nd:YAG capsulotomy rate, as dichotomous data, were tabulated into 2×2 tables and the relative risk ratio (RR) and 95% CIs of the results were compared. Heterogeneity was also assessed through chisquare test, and an *I* ^2^ value greater than 50%, *P*\<0.1 was considered significant. We evaluated the pooled summary effect by using random-effect model. Otherwise(*I* ^2^ value≤50%, *P*≥0.1), data were combined using fixed-effect model to reduce the heterogeneity between studies. Finally, publication bias was assessed visually with funnel plots. The statistical analyses were carried out with RevMan software (version 5.0, The Cochrane Collaboration).

Results {#s3}
=======

Study included {#s3a}
--------------

The results of our research strategy are shown in [Fig. 1](#pone-0077864-g001){ref-type="fig"}. A total of 132 potentially relevant publications were identified through the literature search from multiple databases before May in 2013, 20 of which were based on their titles and abstracts. Only 9 random controlled trials [@pone.0077864-Kugelberg1], [@pone.0077864-Heatley1], [@pone.0077864-Gangwani1]--[@pone.0077864-Hancox1] were eligible for this meta-analysis.

Quality assessment of eligible studies and characteristics of included IOL {#s3b}
--------------------------------------------------------------------------

The methodological quality of trials that were identified and the characteristics of 9 potential RCTs included in the current meta-analysis are presented in [Table 1](#pone-0077864-t001){ref-type="table"}. In these 9 RCTs included in this meta-analysis, the investigators described the random component in a sequence generation process such as: using an envelope [@pone.0077864-Kugelberg1], [@pone.0077864-Gangwani1], [@pone.0077864-Kugelberg2], or referring to a computer random number generator[@pone.0077864-Vasavada1], [@pone.0077864-Kang1]. Only 1 of 9 studies used double-blinding^12^, while the others used single-blinding[@pone.0077864-Kugelberg1], [@pone.0077864-Heatley1], [@pone.0077864-Iwase1]--[@pone.0077864-Hancox1]. Recruited RCTs were carried out in many countries including United Kingdom, Japan, India, Sweden and Korea. The length of the studies was between 1 and 2 years. All studies included described the dropout patients\' number and reasons respectively. Characteristics of IOLs included in the recruited studies are presented in [Table 2](#pone-0077864-t002){ref-type="table"}.

10.1371/journal.pone.0077864.t001

###### Evaluation of the quality of RCTs included in the meta-analysis.

![](pone.0077864.t001){#pone-0077864-t001-1}

  Study               Random         Blind       Withdraw    Jadad score(0--5)
  ---------------- ------------- -------------- ----------- -------------------
  Gangwani 2011     Appropriate   Double-blind   Described           5
  Iwase 2011            Yes           Yes        Described           3
  Vasavada 2011     Appropriate       Yes        Described           4
  Kang 2009             Yes           Yes        Described           3
  Cleary 2009       Appropriate       Yes        Described           4
  Kugelberg 2008    Appropriate       Yes        Described           4
  Hancox 2007           Yes           Yes        Described           3
  Kugelberg 2006    Appropriate       Yes        Described           4
  Heatley 2005          Yes           Yes        Described           3

10.1371/journal.pone.0077864.t002

###### Characteristics of IOLs included in the meta-analysis.

![](pone.0077864.t002){#pone-0077864-t002-2}

  IOLs                 Optic Material      Haptic Material   Lens Type   Optic Diameter   Sharp Edge Design           Optic Shape            Haptic Angulation       Distinctive Feature         PCO evaluation system
  ----------------- --------------------- ----------------- ----------- ---------------- ------------------- ------------------------------ ------------------- ------------------------------ --------------------------
  Acrysof SA60AT     Hydrophobic Acrylic       Acrylic        1-piece         6 mm            Posterior       Anterior Asymmetric biconvex           0                       N/A                AQUA Scheimpflug POCOman
  Acrysof SN60WF     Hydrophobic Acrylic       Acrylic        1-piece         6 mm            Posterior            Posterior biconvex                0                       N/A                          EPCO
  Sensar AR40e       Hydrophobic Acrylic        PMMA          3-piece         6 mm            Posterior              Equal biconvex                  5                       N/A                        POCOman
  Acrysof MA60AC     Hydrophobic Acrylic        PMMA          3-piece         6 mm            Posterior       Anterior Asymmetric Biconvex          10                       N/A                        POCOman
  Acrysof MA30AC     Hydrophobic Acrylic        PMMA          3-piece        5.5 mm            Double         Anterior Asymmetric Biconvex           5                       N/A                        POCOman
  Idea 613XC         Hydrophilic Acrylic       Acrylic        1-piece         6 mm             Double                   Biconvex                     9           Broad optic-haptic junction              AQUA
  Meridian HP60M     Hydrophilic Acrylic        PMMA          1-piece         6 mm             Double              Anterior biconvex                 6                       N/A                      Scheimpflug
  C-flex 570C        Hydrophilic Acrylic       Acrylic        1-piece       5.75 mm            Double                     N/A                        0                       N/A                          EPCO
  Akreos Adapt       Hydrophilic Acrylic       Acrylic        1-piece         6 mm             Double                Equal biconvex                  0                       N/A                          EPCO
  Bio Vue3           Hydrophilic Acrylic        PVDF+         3-piece         6 mm             Double                Equal biconvex                  5           Heparin surface modification           POCOman
  MC611M             Hydrophilic Acrylic       Acrylic        1-piece         6 mm             Double                     N/A                        0           Broad optic-haptic junction            POCOman
  BL27               Hydrophilic Acrylic       Acrylic        1-piece         6 mm            Posterior                   N/A                        0                       N/A                        POCOman
  1CU                Hydrophilic Acrylic       Acrylic        1-piece        5.5 mm            Double                Equal biconvex                  0             4 haptics Accommodation              POCOman
  Centerflex 570H    Hydrophilic Acrylic       Acrylic        1-piece       5.75 mm           Posterior              Equal biconvex                  0                       N/A                        POCOman

Efficacy analysis {#s3c}
-----------------

### Effects of hydrophobic acrylic versus hydrophilic acrylic IOLs on development of posterior capsule opacification in 1-year follow-up {#s3c1}

Based on 7 studies (620 total eyes) that evaluated PCO after a 1-year follow-up period[@pone.0077864-Kugelberg1], [@pone.0077864-Heatley1], [@pone.0077864-Gangwani1], [@pone.0077864-Vasavada1]--[@pone.0077864-Cleary1], [@pone.0077864-Hancox1], hydrophobic acrylic IOLs were associated with significantly lower PCO scores than hydrophilic acrylic IOLs; the SMD was 1.72 (95% CI, 0.82 to 2.63, *P* = 0.0002). The data showed that they had heterogeneity of effect size (*P*\<0.00001, *I* ^2^ = 96%), so the random effect model was used for meta-analysis. The results are shown in [Figure 2](#pone-0077864-g002){ref-type="fig"}.

![Forest plots describing effects of hydrophobic acrylic versus hydrophilic acrylic IOLs on development of posterior capsule opacification in 1-year follow-up.\
(Chi^2^  =  chi square statistic, CI  =  confidence interval, df  =  degrees of freedom, I^2^  =  I-square heterogeneity statistic, IV  =  inverse variance, SMD  =  standard mean difference, Z  =  Z-statistic).](pone.0077864.g002){#pone-0077864-g002}

### Effects of hydrophobic acrylic versus hydrophilic acrylic IOLs on development of posterior capsule opacification in 2-year follow-up {#s3c2}

Seven studies involving 525 eyes used different scales to report the outcomes for PCO after 2-year follow-up [@pone.0077864-Heatley1], [@pone.0077864-Gangwani1]--[@pone.0077864-Vasavada1], [@pone.0077864-Cleary1]--[@pone.0077864-Hancox1]. They also had heterogeneity of effect size (*P*\<0.00001, *I* ^2^ = 94%), so the random effect model was used for meta-analysis. A significant difference was found between the hydrophobic acrylic and hydrophilic acrylic IOLs; the SMD was 1.79 (95% CI, 0.95 to 2.64, *P*\<0.0001), indicating that hydrophobic acrylic IOLs were associated with lower PCO score in 2-year follow-up. The results are shown in [Figure 3](#pone-0077864-g003){ref-type="fig"}.

![Forest plots describing effects of hydrophobic acrylic versus hydrophilic acrylic IOLs on development of posterior capsule opacification in 2-year follow-up.\
(Chi^2^  =  chi square statistic, CI  =  confidence interval, df  =  degrees of freedom, I^2^  =  I-square heterogeneity statistic, IV  =  inverse variance, SMD  =  standard mean difference, Z  =  Z-statistic).](pone.0077864.g003){#pone-0077864-g003}

### Effects of hydrophobic acrylic versus hydrophilic acrylic IOLs on rate of Nd:YAG capsulotomy in 2-year follow-up {#s3c3}

Seven studies[@pone.0077864-Heatley1], [@pone.0077864-Gangwani1]--[@pone.0077864-Vasavada1], [@pone.0077864-Cleary1]--[@pone.0077864-Hancox1] involving 546 eyes compared the Nd:YAG capsulotomy rate of hydrophobic acrylic IOLs with hydrophilic acrylic IOLs in a 2-year follow-up period. No statistical heterogeneity was detected between studies (*P* = 0.85, *I* ^2^ = 0%). Therefore, the fixed effect model was analyzed for this research. The results from analysis suggest that hydrophobic acrylic IOLs had a lower Nd:YAG capsulotomy rate; the RR was 6.96(95% CI, 3.69 to 13.13, *P*\<0.00001). The results are shown in [Figure 4](#pone-0077864-g004){ref-type="fig"}.

![Forest plots describing Effects of hydrophobic acrylic versus hydrophilic acrylic IOLs on rate of Nd:YA Gcapsulotomy in 2-year follow-up.\
(Chi^2^  =  chi square statistic, CI  =  confidence interval, df  =  degrees of freedom, I^2^  =  I-square heterogeneity statistic, IV  =  inverse variance, RR  =  risk ratio, Z  =  Z-statistic).](pone.0077864.g004){#pone-0077864-g004}

Publication Bias {#s3d}
----------------

The publication bias was assessed graphically for each outcome independently using funnel plots. The funnel shaped with the apex near the symmetry, which suggesting publication bias is less of a concern.

Discussion {#s4}
==========

At present, PCO remains the most common complication of modern cataract surgery. There is considerable interest in the impact of IOL on the development of PCO since characteristics and designs of IOLs play a crucial role in preventing PCO. Furthermore, differences in PCO performance between IOLs were likely to reflect their distinction in biomaterials and designs. Both hydrophilic and hydrophobic have been commonly used in cataract surgeries. Hydrophobic acrylic IOLs have a long track record of good PCO rate [@pone.0077864-Leydolt1]. However, due to the mechanical properties, hydrophilic acrylic IOLs may be more suitable for implantation through smaller IOL injection systems [@pone.0077864-Gangwani1]. Additionally they may have superior biocompatibility and less macrophage adhesion especially when a blood-aqueous barrier breakdown has occurred, such as those with glaucoma, uveitis, and diabetes mellitus [@pone.0077864-RichterMueksch1]. Although higher PCO rates have been reported for hydrophilic materials [@pone.0077864-Kugelberg1], [@pone.0077864-Kugelberg2], [@pone.0077864-Findl2], controversy remains over whether this finding is a result of differences in material properties or variation in the optic edge design [@pone.0077864-Werner1]. The potential mechanism that IOLs with sharp optic edge prevent PCO, including cell migration prevention [@pone.0077864-Nagamoto1], pressure atrophy [@pone.0077864-Kang1] and contact inhibition [@pone.0077864-Nishi1], have gained acceptance widely. The PCO rate in hydrophilic acrylic IOLs implantation, which have an improved 360-degree sharp edge, is reported lower than with older hydrophilic models [@pone.0077864-Nishi2], [@pone.0077864-Khandwala1]. It should not be ignored that many studies have a significant limitation, comparing hydrophilic IOLs with round optic edges and hydrophobic IOLs with sharp optic edges [@pone.0077864-Heatley1], [@pone.0077864-AbelaFormanek1], [@pone.0077864-Hayashi1].

Since complete surgical removal lens epithelial cells (LECs) is not possible with modern surgical technology, the migration of remaining equatorial LECs which form PCO may be difficult to avoid. As a proliferative pathological process, there is a close relationship between the severity of PCO and post-operative follow-up time. The longer follow-up period, the better clinicians understand the effect of IOLs on the development of PCO. Some studies have shown no differences in PCO rates between the two different materials IOLs after cataract surgery 1 year [@pone.0077864-Iwase1], [@pone.0077864-Kang1]. Others have shown significantly different results [@pone.0077864-Vasavada1], [@pone.0077864-Cleary1]. Indeed, some researches have addressed the influence of various IOLs on the incidence of PCO in different lengths of follow-up [@pone.0077864-Cheng1], [@pone.0077864-Li1]. Therefore long term randomized controlled trials, especially with a multi center large sample size, are needed to evaluate further effects of various IOL biomaterials with similar optic edge designs in decreasing PCO and Nd:YAG capsulotomy rates.

This meta analysis evaluated the 1-year and 2-year postoperative PCO results and rate of Nd:YAG laser capsulotomy in 2-year follow-up between hydrophilic acrylic and hydrophobic acrylic IOLs implantation respectively. All the IOLs involved in this analysis were designed to prevent PCO by incorporating a sharp edge. Therefore, the differences shown in this analysis may be interpreted primarily based on material effects. The result of this meta-analysis support the theory that compared to hydrophilic acrylic IOLs, hydrophobic acrylic IOLs led to significantly less PCO in 1-year and 2-year follow-up periods. Meanwhile, the rates of Nd:YAG laser capsulotomy were also reduced following hydrophobic acrylic IOLs implantation 2-year post-operation. A reasonable interpretation for the difference in this meta-analysis may be that hydrophobic acrylic IOLs can adhere to collagen membrane [@pone.0077864-Nagata1], leading to tight apposition of IOLs in posterior capsular bag, and advanced adhesiveness through fibronectin [@pone.0077864-Heatley1]. This may result in less space between IOLs and posterior capsule where the LECs could migrate. On the other hand, the hydrophilic surface properties were found to promote proliferation and migration of LECs from the equatorial area to the visual region [@pone.0077864-Dorey1]. Moreover, studies compared electron microscope images and found the edge of hydrophilic IOLs to be less sharp than hydrophobic IOLs at several optical powers [@pone.0077864-Iwase1]. The potential reason could be hydrophilic acrylic IOLs are machined in the dehydrated state and then rehydrated, which can lead to loss of edge sharpness [@pone.0077864-Hancox2]. These differences in manufacturing techniques may explain why hydrophobic IOLs appear to have relatively better PCO performance. The recent study [@pone.0077864-Fujita1] suggest a new aspect to consider in lens material, hybrid technique (hydrophilic center and hydrophobic surface coated IOLs), indicating that hybrid IOLs are less susceptible than hydrophilic IOLs to cell adhesion and less susceptible than hydrophobic IOLs to glistening formation. The copolymer hybrid IOLs may present certain important advantages and should therefore be further evaluated with PCO performance in clinical studies.

The studies in this meta-analysis used a variety of different evaluation systems for PCO analysis, such as Scheimpflug photography system [@pone.0077864-Iwase1], POCOman system [@pone.0077864-Kugelberg1], [@pone.0077864-Heatley1], [@pone.0077864-Kang1]--[@pone.0077864-Hancox1], AQUA (Automated Quantification of After-Cataract system) 12, and EPCO (Evaluation of Posterior Capsule Opacification software) [@pone.0077864-Vasavada1]. Each of these software systems has particular features that made them vulnerable. POCOman and AQUA system are objective, however, they do not incorporate whether PCO is peripheral or central location and show limited points [@pone.0077864-Li1]. EPCO evaluates the construct validity [@pone.0077864-Aslam1], but it is a subjective style. On account of the different analysis systems for PCO across the studies, SMDs were used in this meta-analysis as in previous studies [@pone.0077864-Li1].

Limitation of this meta-analysis may be found. First, even though all the IOLs in this meta-analysis were designed with sharp edge, as a key factor in retarding PCO, there were various extra factor could make an impact. For example, the IOLs with broad optic-haptic junctions [@pone.0077864-Cleary1], the heparin-surface-modified [@pone.0077864-Kang1], the asphericity on the posterior surface [@pone.0077864-Biber1], the degree of haptic angulation [@pone.0077864-Sacu1], and optic size [@pone.0077864-Wren1] appear to exert influence upon PCO formation. The pathophysiology of PCO is multifactorial. Since dissociation of each factor in PCO development is almost impossible, it is very difficult to observe individual elements in clinical practice. Second, although we conducted a thorough electronic search and a manual search of the references of relevant results to minimize selection and publication bias, there were not sufficient studies included to verify if asymmetry exists in a funnel plot. Consequently, long-term postoperative follow-up of multicenter large-sample size randomized controlled trials for PCO development after cataract surgery are necessary.

Supporting Information {#s5}
======================

###### 

PRISMA 2009 Checklist.

(DOC)

###### 

Click here for additional data file.

###### 

PRISMA 2009 Flow Diagram.

(DOC)

###### 

Click here for additional data file.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: Conceived and designed the experiments: YL ZC XT. Performed the experiments: YL JXW. Analyzed the data: YL JXW ZC. Contributed reagents/materials/analysis tools: YL JXW ZC. Wrote the paper: YL JXW.
